{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-096950","form_type":"8-K","ticker":"HCWB","cik":"0001828673","company_name":"HCW Biologics Inc.","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.183367+00:00","generated_at":"2026-05-18T05:49:21.684410+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"HCW Biologics extends $7M license fee payment from WY Biotech to Sept 30, 2025","bullets":["WY Biotech completed due diligence and elected to continue exclusive license agreement with HCW Biologics.","WY Biotech's obligation includes a $7.0 million upfront license fee, originally due earlier.","Parties agreed to extend payment deadline; confirmation of wire transfer expected on or before Sept 30, 2025.","Amendment accommodates WY Biotech's timing for finalizing CDMO and investor agreements."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-096950","json":"https://secwatch.observer/filing/0000950170-25-096950.json","markdown":"https://secwatch.observer/filing/0000950170-25-096950.md","text":"https://secwatch.observer/filing/0000950170-25-096950.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025096950/0000950170-25-096950-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025096950/hcwb-20250714.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:49:21.684410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}